Rezolute (RZLT) Cash from Financing Activities (2010 - 2026)
Rezolute's (RZLT) quarterly Cash from Financing Activities came in at $747000.0 in Q1 2026, up 7370.0% year-on-year from $10000.0 in Q1 2025, and up 109.83% quarter-over-quarter from $356000.0 in Q4 2025.
Rezolute (RZLT) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Rezolute has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $747000.0 for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $747000.0, up 7370.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.2 million (up 48.47% YoY), and the FY2025 annual result was $107.3 million, up 70.28% from the prior year.
- Cash from Financing Activities came in at $747000.0 for Q1 2026 at Rezolute, up from $356000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $101.2 million in Q2 2025 to a low of -$19000.0 in Q1 2022.
- The 4-year median for Cash from Financing Activities is $829000.0 (2025), against an average of $23.2 million.
- Across the five-year window, Cash from Financing Activities sank 83.44% in 2025 and surged 7370.0% in 2026, its largest moves.
- Rezolute's Cash from Financing Activities stood at $11.6 million in 2022, then plunged by 94.32% to $657000.0 in 2024, then slumped by 45.81% to $356000.0 in 2025, then jumped by 109.83% to $747000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $747000.0 (Q1 2026), $356000.0 (Q4 2025), and $911000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 101.16 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Sep 30, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Mar 31, 2024 | -3,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Sep 30, 2022 | 11.57 Mn |
| Sep 30, 2022 | 11.57 Mn |